Alright Pharma Investors, today I’m going to run through a quick profile of a company that I am constantly asked about: Advaxis. The company’s lead product is a Live Attenuated Listeria Vaccine technology titled ADXS11-001 and its designed to fight cervix cancer—don’t worry I’ll explain all that science garble in the next paragraph without a bunch of scientific jargon. » Read more: Advaxis: Can Listeria Really Cure Cancer? The Newest Cancer Technology Out There
-
Search the WEB
-
Custom Search
-
- Pages
- Categories
- Achillion (1)
- ACH-1625 (1)
- Acra (1)
- Acura (4)
- Advaxis (1)
- AEterna Zentaris (1)
- Antigenics (1)
- Arena (3)
- Ariad (1)
- ArQule Inc (1)
- Avanir (4)
- Zenvia (3)
- Biomoda (3)
- Cell Therapeutics (27)
- Opaxio (6)
- Pixantrone (19)
- Celldex (2)
- CombinatoRX (7)
- Exalgo (7)
- cyclacel (1)
- Delcath (2)
- Dendreon (5)
- Dr. Pazdur (2)
- FDA/Events (57)
- Genasense (9)
- Generex (4)
- Genta (9)
- GenVec (4)
- Geron (1)
- Hana Biosciences (2)
- HemispherX (7)
- Ampligen (7)
- Human Genome Sciences (2)
- Immunocellular Therapeutics (1)
- intermune (5)
- Keryx (7)
- Perifosine (7)
- Labopharm (1)
- Lifeline Biotech (1)
- mannkind (3)
- Nektar (2)
- Novelos (1)
- Power 3 (1)
- Pozen (2)
- Rexahn (1)
- Sunesis (9)
- Voreloxin (7)
- Uncategorized (438)
- Vivus (4)
- Qnexa (4)
- YM Biosciences (4)
- ZIOPHARM Oncology (2)
- Achillion (1)
Twitter
